Bio Path Holdings Inc
General ticker "BPTH" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.3M
Bio Path Holdings Inc does not follow the US Stock Market performance with the rate: -43.5%.
Estimated limits based on current volatility of 30.3%: low 0.97$, high 1.81$
Factors to consider:
- Current price 78.1% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [5.06$, 16.37$]
- 2024-12-30 to 2025-12-30 estimated range: [3.37$, 9.91$]
Financial Metrics affecting the BPTH estimates:
- Negative: Non-GAAP EPS, $ of -40.80 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -70.65 <= 2.35
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Negative: negative Net income
Short-term BPTH quotes
Long-term BPTH plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
Operating Expenses | $10.44MM | $13.90MM | $15.84MM |
Operating Income | $-10.44MM | $-13.90MM | $-15.84MM |
Non-Operating Income | $0.00MM | $0.03MM | $-0.23MM |
R&D Expense | $5.91MM | $9.16MM | $11.61MM |
Income(Loss) | $-10.44MM | $-13.87MM | $-16.08MM |
Profit(Loss) | $-10.44MM | $-13.87MM | $-16.08MM |
Stockholders Equity | $25.46MM | $14.17MM | $0.44MM |
Inventory | $0.00MM | $0.00MM | $0.00MM |
Assets | $26.57MM | $15.97MM | $3.22MM |
Operating Cash Flow | $-9.92MM | $-15.10MM | $-11.54MM |
Capital expenditure | $0.07MM | $0.02MM | $0.00MM |
Investing Cash Flow | $-0.07MM | $-0.02MM | $0.00MM |
Financing Cash Flow | $20.01MM | $1.73MM | $2.20MM |
Earnings Per Share* | $-31.04 | $-38.03 | $-33.64 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.